Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon Names Roswell Park Cancer Institute as Certified Service Provider


Exiqon said today that it has signed a "center of excellence" agreement with the Roswell Park Cancer Institute.

Under the agreement, Buffalo, NY-based RPCI will provide real-time PCR services using Exiqon's Mircury LNA Universal RT microRNA PCR products.

Exiqon signed the agreement with Health Research, a non-profit corporation affiliated with RPCI and the New York State Department of Health whose mission is to evaluate, solicit, and administer external financial support for projects and facilitate technology transfer, according to the company's website.

The agreement is the latest under Exiqon's certified service provider program. In August, Exiqon established a similar COE at the Oncogenomics Core Facility in the University of Miami School of Medicine (PCR Insider, 8/23/11).

Also, in June, Exiqon named Sweden's Tataa Biocenter and South Korea's Bioneer as COEs; and in November 2009 the company named Harvard University's ICCB-Longwood Screening Facility as a microRNA screening COE.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.